NM_019109.5:c.840G>C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_019109.5(ALG1):​c.840G>C​(p.Leu280Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0499 in 1,611,694 control chromosomes in the GnomAD database, including 2,297 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. L280L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.047 ( 218 hom., cov: 33)
Exomes 𝑓: 0.050 ( 2079 hom. )

Consequence

ALG1
NM_019109.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.802

Publications

6 publications found
Variant links:
Genes affected
ALG1 (HGNC:18294): (ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase) The enzyme encoded by this gene catalyzes the first mannosylation step in the biosynthesis of lipid-linked oligosaccharides. This gene is mutated in congenital disorder of glycosylation type Ik. [provided by RefSeq, Dec 2008]
ALG1 Gene-Disease associations (from GenCC):
  • ALG1-congenital disorder of glycosylation
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 16-5078856-G-C is Benign according to our data. Variant chr16-5078856-G-C is described in ClinVar as [Benign]. Clinvar id is 95937.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.802 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0527 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALG1NM_019109.5 linkc.840G>C p.Leu280Leu synonymous_variant Exon 7 of 13 ENST00000262374.10 NP_061982.3 Q9BT22-1
ALG1NM_001438123.1 linkc.840G>C p.Leu280Leu synonymous_variant Exon 7 of 12 NP_001425052.1
ALG1NM_001330504.2 linkc.507G>C p.Leu169Leu synonymous_variant Exon 7 of 13 NP_001317433.1 Q9BT22-2
ALG1XR_007064892.1 linkn.847G>C non_coding_transcript_exon_variant Exon 7 of 10

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALG1ENST00000262374.10 linkc.840G>C p.Leu280Leu synonymous_variant Exon 7 of 13 1 NM_019109.5 ENSP00000262374.5 Q9BT22-1

Frequencies

GnomAD3 genomes
AF:
0.0470
AC:
7155
AN:
152190
Hom.:
218
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0517
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0441
Gnomad ASJ
AF:
0.0738
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0108
Gnomad FIN
AF:
0.0188
Gnomad MID
AF:
0.0918
Gnomad NFE
AF:
0.0541
Gnomad OTH
AF:
0.0559
GnomAD2 exomes
AF:
0.0388
AC:
9626
AN:
248140
AF XY:
0.0385
show subpopulations
Gnomad AFR exome
AF:
0.0513
Gnomad AMR exome
AF:
0.0352
Gnomad ASJ exome
AF:
0.0676
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.0205
Gnomad NFE exome
AF:
0.0529
Gnomad OTH exome
AF:
0.0509
GnomAD4 exome
AF:
0.0502
AC:
73191
AN:
1459386
Hom.:
2079
Cov.:
62
AF XY:
0.0487
AC XY:
35370
AN XY:
726032
show subpopulations
African (AFR)
AF:
0.0509
AC:
1702
AN:
33406
American (AMR)
AF:
0.0358
AC:
1598
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.0683
AC:
1782
AN:
26098
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39696
South Asian (SAS)
AF:
0.0100
AC:
863
AN:
86144
European-Finnish (FIN)
AF:
0.0205
AC:
1090
AN:
53174
Middle Eastern (MID)
AF:
0.0887
AC:
378
AN:
4260
European-Non Finnish (NFE)
AF:
0.0562
AC:
62498
AN:
1111714
Other (OTH)
AF:
0.0544
AC:
3277
AN:
60202
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.446
Heterozygous variant carriers
0
4645
9290
13936
18581
23226
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2314
4628
6942
9256
11570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0470
AC:
7162
AN:
152308
Hom.:
218
Cov.:
33
AF XY:
0.0441
AC XY:
3284
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.0518
AC:
2155
AN:
41578
American (AMR)
AF:
0.0441
AC:
674
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0738
AC:
256
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.0112
AC:
54
AN:
4830
European-Finnish (FIN)
AF:
0.0188
AC:
200
AN:
10620
Middle Eastern (MID)
AF:
0.0816
AC:
24
AN:
294
European-Non Finnish (NFE)
AF:
0.0541
AC:
3681
AN:
68026
Other (OTH)
AF:
0.0553
AC:
117
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
347
695
1042
1390
1737
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
80
160
240
320
400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0432
Hom.:
61
Bravo
AF:
0.0490
Asia WGS
AF:
0.00895
AC:
31
AN:
3478
EpiCase
AF:
0.0594
EpiControl
AF:
0.0602

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Feb 08, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Mar 24, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ALG1-congenital disorder of glycosylation Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 19, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ALG1-related disorder Benign:1
Dec 01, 2023
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
7.3
DANN
Benign
0.75
PhyloP100
0.80
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12921879; hg19: chr16-5128857; API